Facebook
X
LinkedIn
Forward
Cardio-Kidney Metabolic Health with a Focus on Weight Management
SAMPLE ONLY
This live satellite symposium equips primary care clinicians with a practical framework for managing cardiovascular-kidney-metabolic (CKM) syndrome. Faculty will review CKM staging and cardiovascular risk stratification to help clinicians prioritize care, then walk through practical assessment tools for adiposity, glycemia, lipids, kidney function, and related liver and sleep disorders.
The session translates these assessments into individualized weight-management plans, covering behavioral interventions, pharmacotherapy, and when to refer for metabolic/bariatric surgery. Faculty will compare available therapies on weight-loss efficacy, risk-factor improvement, and proven clinical outcomes, helping clinicians match treatment to patient needs.
The program concludes with guidance on monitoring, adjusting treatment, and referral decision-making, factoring in effectiveness, safety, access, and long-term disease management.
Target Audience
This activity has been designed to meet the educational needs of primary care physicians who provide concierge medicine to their patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply CKM staging and appropriate cardiovascular risk assessment to identify clinical priorities in primary care.
- Select and interpret practical assessments of adiposity, glycemia, lipids, kidney health, and associated liver and sleep-related conditions.
- Develop individualized weight-management plans incorporating behavioral interventions, pharmacotherapy, and metabolic/bariatric surgery referral when appropriate.
- Distinguish weight-loss efficacy, risk-factor improvement, and demonstrated clinical outcome benefits across therapies.
- Establish monitoring, treatment-adjustment, and referral plans that address effectiveness, safety, access, and long-term disease management.
Course summary
SAMPLE ONLY
Activity Title
Satellite Symposium: Cardio-Kidney Metabolic Health with a Focus on Weight Management
Activity Date and Location
April 9, 2027 at the Gaylord Palms Resort & Convention Center
Joint Providership Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Cardiometabolic Health Congress (CMHC). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
Pharmacy Continuing Education
Partners designates this continuing education activity for 2.0 contact hour(s) (0.2 CEUS) of the Accreditation Council for Pharmacy Education.
Dietitian Continuing Education
This program offers 4.25* CPEUs for dietitians.
Registration Fee Information
There is a registration fee for participating and receiving CME/CE credit for this educational activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact our event registration team at [email protected]. REPLACE THIS EMAIL
How to Request CE Credit
TBD
Disclosures
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Information on faculty disclosures will be available before the meeting.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guid